cover image: Pepgen Receives u.s. Fda Fast Track Designation for PGN-Edodm1 for the Treatment of Myotonic Dystrophy Type 1

Pepgen Receives u.s. Fda Fast Track Designation for PGN-Edodm1 for the Treatment of Myotonic Dystrophy Type 1

2024

Pages
2
Published in
United States of America